At a glance
- Regulatory status
- Testosterone pellets for subcutaneous implantation are an FDA-approved prescription medicine; the cited label's uses include replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone.[3]
- Half-life
- An apparent terminal half-life of 70.8 days (plus or minus 10.7) in 14 hypogonadal men after six 200 mg pellets, in a single-dose, open-label study; the 75 mg pellet's label gives no half-life.[1]
- Route
- Subcutaneous implantation, per the label.[3]
- Category
- Testosterone & TRT
- Vial size
- Not listed
The pellet presentation changes the relevant units entirely. Count and mass matter, while liquid concentration and syringe markings do not. The 75 mg-per-pellet figure is a label fact; the long apparent half-life concerns an implant reference, not a conventional vial.[3][1]
What the research says
The cited study examined subcutaneous testosterone implants in men with hypogonadism. Fourteen participants underwent detailed pharmacokinetic sampling after implantation of six 200 mg pellets; additional participants contributed feasibility and adverse-event observations. The study's pellet strength differs from the label's 75 mg pellet.[1][3]
Investigators followed testosterone, gonadotropins, dihydrotestosterone, estradiol, and binding proteins over months. They observed an initial release peak, a prolonged plateau, and a later decline. The reported apparent terminal half-life was approximately 71 days, reflecting the implanted formulation's release and disposition together.[1]
The study also evaluated local complications and patient acceptance. Its long observation period provides context for depot behavior, but its 200 mg research pellets cannot substantiate a different product's package size. A separately cited product label supplies the 75 mg identity used for the count-only example below.[1][3]
Cited amounts
The cited label identifies 75 mg of testosterone per pellet. This implant presentation supports count-to-mass arithmetic. The pharmacokinetic paper used a different, 200 mg pellet and is not the source for this package fact.[3]
Open the calculator for amount conversionsHalf-life and timing
An apparent terminal half-life of 70.8 days (plus or minus 10.7) in 14 hypogonadal men after six 200 mg pellets, in a single-dose, open-label study; the 75 mg pellet's label gives no half-life.[1]
Continue to the calculatorReconstitution
The primary example comes from the cited label: each pellet contains 75 mg of testosterone, so two pellets represent 150 mg of inventory. This is a count-to-mass relationship for a solid implant. It does not select an implantation amount or turn a pellet into a liquid preparation. The label supports the 75 mg package fact independently of the study that investigated a different pellet strength.[3]
Tracking it in PinPoint
From a reference to a record
Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Track vials and prefilled pens side by side.[2]
The Home curve models your levels between doses from an estimate built on the half-life value stored for each compound, published where a published value exists and an estimate where none does. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.
Get PinPoint on the App StoreFrequently asked questions
- Can testosterone pellets use a reconstitution calculator?
- Pellet records use count multiplied by 75 mg per pellet, per the label. They are implants, not powder vials for water addition. The calculator link is a general arithmetic resource; this guide does not invent liquid volume or syringe units for an implant.[3]
- Can syringe markings represent a testosterone pellet count?
- The implant is recorded by count and mass, not by liquid volume. The label's 75 mg-per-pellet figure can translate a pellet count into milligrams. There is no sourced liquid denominator from which to calculate syringe markings.[3]
- Does the pellet half-life describe an injection?
- No. The cited study reports a 70.8-day apparent terminal half-life for crystalline testosterone pellets implanted under the skin. Cypionate, enanthate, and undecanoate have separate injection records. The shared testosterone identity does not make their presentation-specific figures interchangeable.[1]
Sources
Sources checked against the cited documents on 19 November 2026.
- Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men, 1996 (PubMed 8796140)Abstract read 19 November 2026 (single-dose, open-label, non-randomized; six 200 mg pellets in 14 hypogonadal men; 36 more men for feasibility and side-effects). Full text not opened.Retrieved 2026-11-19 · human-study
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
- Testosterone pellets for subcutaneous implantation, prescribing information (DailyMed, SPL effective 17 July 2025)Read 19 November 2026: Description, clinical pharmacology, Indications. Each pellet contains 75 mg testosterone, unlike the 200 mg pellets in the cited study; the label gives no half-life.Retrieved 2026-11-19 · label
